Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Gonzalez-Angulo

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|March 23, 2010
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survivalWendy A Woodward, Pauline T Truong, Tse-Kuan Yu, et al.
Molecular Cancer Therapeutics|September 30, 2010
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancerDavid Luyimbazi, Argun Akcakanat, Priscilla F McAuliffe, et al.
Cancer|October 19, 2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancerStacy Moulder, Gregory Gladish, Joe Ensor, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancerLeonel F Hernandez-Aya, Mariana Chavez-Macgregor, Xiudong Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacodynamic markers of perifosine efficacyBryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Breast Cancer Research : BCR|August 17, 2017
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancerNatalia Paez Arango, Erkan Yuca, Ming Zhao, et al.
Cancer|August 19, 2007
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique diseaseMassimo Cristofanilli, Vicente Valero, Aman U Buzdar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Plos One|April 8, 2016
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast CancerYoung Kwang Chae, Debora de Melo Gagliato, Sachin Gopalkrishna Pai, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|March 23, 2010
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survivalWendy A Woodward, Pauline T Truong, Tse-Kuan Yu, et al.
Molecular Cancer Therapeutics|September 30, 2010
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancerDavid Luyimbazi, Argun Akcakanat, Priscilla F McAuliffe, et al.
Cancer|October 19, 2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancerStacy Moulder, Gregory Gladish, Joe Ensor, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancerLeonel F Hernandez-Aya, Mariana Chavez-Macgregor, Xiudong Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacodynamic markers of perifosine efficacyBryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Breast Cancer Research : BCR|August 17, 2017
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancerNatalia Paez Arango, Erkan Yuca, Ming Zhao, et al.
Cancer|August 19, 2007
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique diseaseMassimo Cristofanilli, Vicente Valero, Aman U Buzdar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Plos One|April 8, 2016
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast CancerYoung Kwang Chae, Debora de Melo Gagliato, Sachin Gopalkrishna Pai, et al.
Pageof 8